Koike Shinsuke, Tanaka Saori C, Hayashi Takuya
University of Tokyo Institute for Diversity and Adaptation of Human Mind, The University of Tokyo, Tokyo 153-8902, Japan; Center for Evolutionary Cognitive Sciences, Graduate School of Arts and Sciences, The University of Tokyo, Tokyo 153-8902, Japan; The International Research Center for Neurointelligence (WPI-IRCN), The University of Tokyo Institutes for Advanced Study (UTIAS), Tokyo 113-8654, Japan.
Brain Information Communication Research Laboratory Group, Advanced Telecommunications Research Institute International, Kyoto 619-0288 Japan; Division of Information Science, Nara Institute of Science and Technology, Nara 630-0192, Japan.
Neurosci Biobehav Rev. 2025 Apr;171:106063. doi: 10.1016/j.neubiorev.2025.106063. Epub 2025 Feb 26.
Recent magnetic resonance imaging (MRI) research has advanced our understanding of brain pathophysiology in psychiatric disorders. This progress necessitates re-evaluation of the diagnostic system for psychiatric disorders based on MRI-based biomarkers, with implications for precise clinical diagnosis and optimal therapeutics. To achieve this goal, large-scale multi-site studies are essential to develop a standardized MRI database, with the analysis of several thousands of images and the incorporation of new data. A critical challenge in these studies is to minimize sampling and measurement biases in MRI studies to accurately capture the diversity of disease-derived biomarkers. Various techniques have been employed to consolidate datasets from multiple sites in case-control studies. Traveling subject harmonization stands out as a powerful tool that can differentiate measurement bias from sample variety and sampling bias. A non-linear statistical model for a normative trajectory across the lifespan also strengthens the database to mitigate sampling bias from known factors such as age and sex. These approaches can enhance the alterations between psychiatric disorders and integrate new data and follow-up scans into existing life-course trajectory, enhancing the reliability of machine learning classification and subtyping. Although this approach has been developed using T1-weighted structural image features, future research may extend this framework to other modalities and measures. The required sample size and methodological establishment are needed for future investigations, leading to novel insights into the brain pathophysiology of psychiatric disorders and the development of optimal therapeutics for bedside clinical applications. Sharing big data and their findings also need to be considered.
最近的磁共振成像(MRI)研究推动了我们对精神疾病大脑病理生理学的理解。这一进展使得有必要基于MRI生物标志物重新评估精神疾病的诊断系统,这对精确的临床诊断和最佳治疗具有重要意义。为实现这一目标,大规模多中心研究对于建立标准化的MRI数据库至关重要,需要分析数千张图像并纳入新数据。这些研究中的一个关键挑战是尽量减少MRI研究中的采样和测量偏差,以准确捕捉疾病衍生生物标志物的多样性。在病例对照研究中,已采用各种技术来整合来自多个中心的数据集。移动受试者标准化作为一种强大的工具脱颖而出,它可以区分测量偏差与样本差异和采样偏差。一种用于整个生命周期规范轨迹的非线性统计模型也加强了数据库,以减轻年龄和性别等已知因素造成的采样偏差。这些方法可以增强精神疾病之间的差异,并将新数据和随访扫描整合到现有的生命历程轨迹中,提高机器学习分类和亚型分析的可靠性。尽管这种方法是利用T1加权结构图像特征开发的,但未来的研究可能会将这个框架扩展到其他模态和测量方法。未来的研究需要确定所需的样本量并建立方法,从而对精神疾病的大脑病理生理学有新的认识,并开发出适用于床边临床应用的最佳治疗方法。还需要考虑大数据及其研究结果的共享。